1. Home
  2. HALO vs GVA Comparison

HALO vs GVA Comparison

Compare HALO & GVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$74.99

Market Cap

8.1B

Sector

Health Care

ML Signal

HOLD

Logo Granite Construction Incorporated

GVA

Granite Construction Incorporated

HOLD

Current Price

$160.15

Market Cap

6.6B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
HALO
GVA
Founded
1998
1922
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Military/Government/Technical
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.1B
6.6B
IPO Year
2001
1995

Fundamental Metrics

Financial Performance
Metric
HALO
GVA
Price
$74.99
$160.15
Analyst Decision
Buy
Hold
Analyst Count
11
3
Target Price
$78.64
$118.33
AVG Volume (30 Days)
1.6M
733.9K
Earning Date
05-05-2026
04-30-2026
Dividend Yield
N/A
0.42%
EPS Growth
N/A
47.33
EPS
1.22
N/A
Revenue
$151,862,000.00
$1,762,965,000.00
Revenue This Year
$28.24
$13.26
Revenue Next Year
$12.56
$6.92
P/E Ratio
$59.53
N/A
Revenue Growth
N/A
N/A
52 Week Low
$51.06
$89.80
52 Week High
$82.22
$157.54

Technical Indicators

Market Signals
Indicator
HALO
GVA
Relative Strength Index (RSI) 66.87 76.40
Support Level $62.53 $116.73
Resistance Level $79.50 N/A
Average True Range (ATR) 2.20 4.73
MACD 0.30 1.69
Stochastic Oscillator 84.09 98.07

Price Performance

Historical Comparison
HALO
GVA

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About GVA Granite Construction Incorporated

Granite Construction Inc engages in the construction and development of various infrastructure projects on behalf of public and private clients in the United States. The company focuses on heavy civil infrastructure projects, including roads, highways, transit facilities, airports, bridges, dams, tunnels, and other infrastructure projects. In addition, the company performs site preparation and infrastructure services for residential development, energy development, and other facilities. The majority of revenue is derived from the company's Construction operating segment, and rest from Materials segment.

Share on Social Networks: